Moderna says their COVID-19 vaccine is 94.5 percent effective in early analysis

4:45am PST - November 16th, 2020    moderna - The Verge

Moderna, the first company to send a COVID-19vaccine candidate to clinical trials in the US, has just announced early results that indicate their mRNA-based coronavirus vaccine is highly effective.